You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
健民集團(600976.SH):擬向銀行申請授信額度
格隆匯 04-03 16:59

格隆匯4月3日丨健民集團(600976.SH)公佈,公司2020年4月3日以通訊方式召開第九屆董事會第五次會議,會議全票審議通過了“關於公司及全資子公司向銀行申請綜合授信額度的議案”、“關於控股子公司福高藥業向銀行申請授信額度的議案”;

同意公司、全資子公司健民集團葉開泰國藥(隨州)有限公司(以下簡稱:葉開泰國藥)、控股子公司健民藥業集團廣東福高藥業有限公司(以下簡稱:福高公司)分別向銀行申請授信額度,以滿足經營所需。

授信銀行:漢口銀行股份有限公司公司授信額度:綜合授信3.5億元,淨敞口1億元其中動資金貸款額度1億元、淨敞口1億元;低風險業務額度2.5億元,無淨敞口,品種為銀行承兑匯票貼現、國內信用證、國內信用證議付,品種間額度可串用,用於滿足公司日常經營。

葉開泰國藥授信額度:綜合授信2億元,淨敞口1億元。其流動資金貸款額度1億元、淨敞口1億元;銀行承兑匯票貼現額度0.5億元,福費廷額度0.5億元,銀承貼現、福費廷間額度串用,用於滿足葉開泰國藥日常經營。

上述授信額度中公司流動資金貸款額度葉開泰國藥流動資金貸款額度之間可以互換

授信銀行:匯豐銀行(中國)有限公司武漢分行授信金額:授信額度最高限額為4200萬元主要用於商業承票貼現業務

福高公司最終授信額度將以實際審批的授信額度為準,具體融資金額將視福高公司經營實際需求確定。

上述融資額度的申請無需提交股東大會審批,公司董事會授權總裁班子辦理上述授信事宜,按照公司經營所需具體辦理貸款、貼現等融資業務,並簽署有關銀行合同及文件規定的所有登記、備案和資料提供等事宜

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account